31 research outputs found

    Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1

    Get PDF
    Background: Antibodies targeting variant antigens expressed on the surface of Plasmodium falciparum infected erythrocytes have been associated with protection from clinical malaria. The precise target for these antibodies is unknown. The best characterized and most likely target is the erythrocyte surface-expressed variant protein family Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). Methods: Using recombinant proteins corresponding to five domains of the expressed A4 var gene, A4 PfEMP1, the naturally occurring antibody response was assessed, by ELISA, to each domain in serum samples obtained from individuals resident in two communities of differing malaria transmission intensity on the Kenyan coast. Using flow cytometry, the correlation in individual responses to each domain with responses to intact A4-infected erythrocytes expressing A4 PfEMP1 on their surface as well as responses to two alternative parasite clones and one clinical isolate was assessed. Results: Marked variability in the prevalence of responses between each domain and between each transmission area was observed, as wasa strong correlation between age and reactivity with some but not all domains. Individual responses to each domain varied strikingly, with some individuals showing reactivity to all domains and others with no reactivity to any, this was apparent at all age groups. Evidence for possible cross-reactivity in responses to the domain DBL4γ was found. Conclusion: Individuals acquire antibodies to surface expressed domains of a highly variant protein. The finding of potential cross-reactivity in responses to one of these domains is an important initial finding in the consideration of potential vaccine targets

    Macroscopic stability of high β MAST plasmas

    No full text
    The high-beta capability of the spherical tokamak, coupled with a suite of world-leading diagnostics on MAST, has facilitated significant improvements in the understanding of performance-limiting core instabilities in high performance plasmas. For instance, the newly installed motional Stark effect diagnostic, with radial resolutio

    Alpha-particle velocity-space diagnostic in ITER

    No full text
    We discuss α-particle velocity-space diagnostic in ITER based on the planned collective Thomson scattering (CTS) and γ-ray spectrometry (GRS) systems as well as ASCOT simulations of the α-particle distribution function. GRS is sensitive to α-particles with energies MeV at all pitches p, and CTS for MeV and . The remaining velocity space is not observed. GRS and CTS view the plasma (almost) perpendicularly to the magnetic field. Hence we cannot determine the sign of the pitch of the α-particles and cannot distinguish co- and counter-going α-particles with the currently planned α-particle diagnostics. Therefore we can only infer the sign-insensitive 2D distribution function by velocity-space tomography for MeV. This is a serious limitation, since co- and counter-going α-particle populations are expected to have different birth rates and neoclassical transport as well as different anomalous transport due to interaction with modes such as Alfvén eigenmodes. We propose the installation of an oblique GRS system on ITER to allow us to diagnostically track such anisotropy effects and to infer the full, sign-sensitive for MeV. α-particles with MeV are diagnosed by CTS only, which does not allow velocity-space tomography on its own. Nevertheless, we show that measurements of the α-particle energy spectrum, which is an ITER measurement requirement, are now feasible for MeV using a velocity-space tomography formalism assuming isotropy in velocity space
    corecore